Perspective

• Yes, Patients Are Getting More Complicated   It's not your imagination. Those problem lists are getting longer all the time, but the resources to deal with them are shrinking.
  Medscape, January 08, 2024
• Experiencing the Evolution of Early NSCLC Treatment   Jared Weiss, MD, reflects on his first encounter in training with a patient with early NSCLC and how the treatment landscape has rapidly changed since then.
  Medscape, January 08, 2024
• Early NSCLC: Three Forms That Contribute to Failure to Diagnose   Jared Weiss, MD, reflects on the profound impact of patient experiences in which early diagnosis of NSCLC was missed.
  Medscape, January 08, 2024
• Cannabis for Psychiatric Disorders? Experts Weigh In   Steve Strakowski, Leslie Hulvershorn, and Christopher Hammond discuss the role of cannabis in psychiatric disorders.
  Medscape Psychiatry, January 08, 2024
• Study Identifies CV Comorbidities Linked to Dermatomyositis The results "represent potential areas for preventative intervention," the researchers wrote.
  Medscape Medical News, January 08, 2024
• New Tool May Offer Diagnostic Edge for Diabetic Neuropathy Researchers adapted optical diffusion technology in a low-cost portable device to assess microvascular blood flow in human skin and showed proof of concept in early detection of diabetic neuropathy.
  Medscape Medical News, January 08, 2024
• Medscape Medical Minute   Dr Perry Wilson highlights the day's top news stories, produced by Medscape, the leading source of information for medical professionals. From new clinical evidence to breaking policy news, stay on the pulse of medicine with Medscape Medical Minute.
  Medscape Medical News, January 08, 2024
• Intermittent Energy Restriction Tied to Gut, Brain Changes Losing weight via intermittent energy restriction can curb brain activity related to eating behavior and increase microbial diversity in the gut in individuals with obesity.
  Medscape Medical News, January 08, 2024
• Gastric Cancer Survival Differs by Race and Ethnicity Overall, Asian and Hispanic patients demonstrated better survival than White and Black patients.
  Medscape Medical News, January 08, 2024
• Targeting IDH Mutated Glioma: A Decade’s Journey from Bench to Bedside. Prof Tim Cloughesy reviews the key early development milestones that lead to the evaluation of Vorasidenib in the INDIGO trial.
  Medscape Medical Affairs, January 08, 2024
• Medicare Bundled Payment Model Fails to Boost HF Outcomes Medicare's bundled payment model was not associated with changes in process-of-care measures or early outcomes after hospitalization for heart failure, a new study reported.
  Medscape Medical News, January 08, 2024
• Intensive Weight Loss Does Not Ease Gout Symptoms Researchers found an association between weight loss and a corresponding reduction in serum urate, but more weight loss did not result in positive changes in pain or fatigue.
  Medscape Medical News, January 08, 2024
• Navigating the Paradigm Shift: A New Era of Glioma Care. Hear Prof Ghazaleh Tabatabai discuss how new clinical data and the application of ‘Personalised Treatment Strategies’ is impacting the care of glioma patients.
  Medscape Medical Affairs, January 07, 2024
• The Microbiome: It's What's Inside That Counts   The microbiome is the constellation of microscopic organisms that call the human body home, and its clinical implications are becoming increasingly clear to physicians.
  Medscape Gastroenterology, January 05, 2024
• Healthcare Violence: Docs Bear Brunt of Business Pressures   Mark A. Lewis, MD, discusses violence in healthcare, including a recent experience with a patient.
  Medscape Oncology, January 05, 2024
• Jan 05 2024 This Week in Cardiology   Neuro-modulation in HF, private equity owned hospitals, HCM, SCD and ICD re-evaluated, and peer review are the topics John Mandrola, MD, discusses in this week's podcast.
  theheart.org on Medscape, January 05, 2024
• Do Statins Offset Venous Thrombosis Risk With Hormone Therapy?   Statins might offer a way to reduce the risk for a potentially serious adverse effect of hormone therapy.
  Medscape Ob/Gyn, January 05, 2024
• Magnetic Seeds/Guidewires for Breast Cancer Localization? Paramagnetic seeds work as well as guidewires for breast tumor localization and are easier to use, but it's not yet clear whether the costs of the seeds outweigh the benefits.
  Medscape Medical News, January 05, 2024
• Impact of Pregnancy on Rosacea Unpredictable, Study Suggests Nearly half of study participants reported that their rosacea worsened when they were pregnant.
  Medscape Medical News, January 05, 2024
• A Snapshot of Ulcerative Colitis: Part I Watch this patient case study presented by Dr Deborah Fisher for a snapshot of uncontrolled ulcerative colitis and to learn more about what the current guidelines recommend in this situation.
  Medscape Medical Affairs, January 05, 2024
• Mortality Still Significant in High-Risk PE Despite Advances A new study showed continued high rates of in-hospital mortality in patients with high-risk PE, despite advances in treatment and creation of PE response teams.
  Medscape Medical News, January 05, 2024
• Long-term Clopidogrel Has Advantages After Coronary Stenting Clopidogrel after PCI was noninferior to aspirin for net adverse clinical events but superior in reducing secondary endpoints of stroke and MI, in 5-year STOPDAPT-2 results.
  Medscape Medical News, January 05, 2024
• Changes in the Treatment Landscape of Early-Stage Non-Small Cell Lung Cancer   Narjust Florez, MD, reflects on the significant changes in the treatment landscape of early-stage non-small cell lung cancer in recent years.
  Medscape, January 04, 2024
• Top Studies in Neurology From 2023   Christoph Diener discusses 10 top neurology studies from 2023 covering new drugs for Alzheimer's disease and advances in migraine.
  Medscape Neurology, January 04, 2024
• US Dermatologic Drug Approvals Rose Between 2012 and 2022 Of the 52 new drugs approved in the past decade, 21% were categorized as first in class, but more innovations are needed for skin diseases with unmet therapeutic needs, the authors said.
  Medscape Medical News, January 04, 2024
• Prior Auth Tied to Delays, Discontinuation of Cancer Meds The introduction of a new prior authorization requirement for an established oral anticancer regimen led to more treatment delays and discontinuations among Medicare beneficiaries.
  Medscape Medical News, January 04, 2024
• 5 Things to Know About Antifungal Therapeutic Drug Monitoring Antifungal therapeutic drug monitoring is a useful but underutilized tool in antifungal stewardship, experts say.
  CDC Expert Commentary, January 03, 2024
• Is It Time to Air Grievances? 'Twas the night before Festivus and all through the house, everyone was griping.
  MDedge, January 03, 2024
• Mechanisms of Hypothalamic Inflammation in Obesity Dr Adam Gilden explores the challenges in managing hypothalamic obesity, and a multidisciplinary approach to address the specific needs of individuals affected by this multifaceted condition.
  Medscape Diabetes & Endocrinology, January 03, 2024
• Circadian BP Shifts Earlier in Children With MS OSA Sleep monitoring data suggested that tracking disturbances could help map blood pressure dysregulation in young patients.
  Medscape Medical News, January 03, 2024
• Optimal Follow-up After Cervical Cancer Surgery Instead of using a one-size-fits-all approach, monitoring for cancer recurrence after fertility-sparing cervical cancer surgery can be tailored based on HPV testing and cytology.
  Medscape Medical News, January 03, 2024
• Artificial Sweeteners Alter the Duodenal Microbiome Nonsugar sweeteners affected the stool and small bowel microbiomes differently, and the type of sweetener consumed proved relevant to which microbiome changes occurred.
  Medscape Medical News, January 03, 2024
• Myelofibrosis Highlights From ASH 2023   Key studies on myelofibrosis, presented at ASH 2023, include the phase 3 MANIFEST-2 study, the phase 3 Transform-1 study, and multiple studies on treating anemia in myelofibrosis.
  Medscape, January 02, 2024
• Clinical Takeaways in Thrombocytopenia From ASH 2023   Clinical takeaways in immune thrombocytopenia (ITP) from ASH 2023 include efficacy of novel therapies, infection risk in chronic ITP, and ITP effects during pregnancy, as reported by Dr Howard Liebman.
  Medscape, January 02, 2024
• New Research Points to a Better Biomarker for MSI mCRC   David J. Kerr, CBE, MD, DSc, discusses the potential for identifying patients who are likely to be more responsive to immune checkpoint inhibitors.
  Medscape Oncology, January 02, 2024
• An Alternative to Walking Out There are a growing number of hospitals and clinics where nurses and physicians are exploring the possibility of organizing to give themselves a stronger voice in how healthcare is being delivered.
  MDedge, December 19, 2023
• Supercharge Your Medical Practice With ChatGPT An expert on artificial intelligence in oncology describes why, and how, to integrate ChatGPT into your clinical practice.
  Medscape Oncology, December 13, 2023
• Antiobesity Drugs in OA: Slow, Moderate Approach Deemed Best Rapid weight loss with antiobesity drugs had no significant impact on reduced mortality in a population-based study of more than 6000 adults with knee or hip osteoarthritis.
  Medscape Medical News, December 11, 2023
• Wide Regional Variation in Diagnosis of Long COVID The percentage of patients with a U09.9 diagnostic code in the year after a SARS-CoV-2 infection ranged from less than 4% in one region to more than 24% in another
  Medscape Medical News, December 08, 2023
• Mass Shooters and Mental Illness: Reexamining the Connection Given the current tragically violent landscape both at home and in Israel and Palestine, the 'desire for destruction' is vital to understand.
  MDedge, December 06, 2023